Real Stories of lives made simpler.
Thousands of Omnipod® users remember what life was like before discovering the tubeless, waterproof*, wearable insulin Pod. Check out real stories of how Omnipod has made meaningful differences, both big and small.
I feel like it’s part of me and wants me to be the best I can be.
Podder since 2009
I have the freedom to do everything I did before I went on insulin.
Podder since 2019
I’m now the driver of my disease instead of a passenger.
Podder since 2012
Omnipod 5 Automated Insulin Delivery System
Omnipod® 5 User Testimonial: Meet Alvin and Mattie
Omnipod® 5 User Testimonial: Meet Morgan
Omnipod® 5 User Testimonial: Meet Christian
Omnipod® 5 User Testimonial: Meet Dwight and Gracie
Omnipod DASH® Insulin Delivery System
As someone living with insulin-requiring type 2 diabetes, David calls Omnipod a lifesaver—plain and simple. He now has more energy than ever before, and gets to put less of it towards managing diabetes.
97% of users would recommend to a friend
SOURCE: In a November 2019 satisfaction survey of 2,481 Omnipod DASH and Omnipod System users, 97% of respondents, if given the opportunity, would recommend the Omnipod System to a friend or colleague. Insulet data on file.
Reviews from the diabetes community
"My daughter Arden has been wearing an Omnipod everyday since 2006 and it has been a constant friend in her life with diabetes. Consistent. Tubeless. Worry-free.
Because Omnipod is tubeless, my daughter's activities are never a problem. Arden loves sports, so not having to worry about her insulin pump during a softball game or swimming is huge! Omnipod also makes everyday things, like bathing, much easier because she doesn't have to disconnect."
- Juicebox podcast host Scott Benner
"As the only insulin pump in the United States that does not connect to your body via tubing, Omnipod is unique in what it offers to people with diabetes."
"I'm really excited to finally have [Omnipod 5] on the market, and I can't wait to start using it in my patients."
- Anne L. Peters, M.D.
Ready to take the next step?
Get started by checking your coverage for Omnipod products, or start with a no- commitment, free 30-day Omnipod DASH trial†.
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Personal Diabetes Manager (PDM) and Controller are not waterproof.
Important Safety Information:
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®.
The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.
Warning: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.
Warning: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.
The Omnipod DASH® Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin. Additionally, the Omnipod DASH® System is interoperable with a compatible blood glucose meter to receive and display blood glucose measurements. The Omnipod DASH® System has been tested and found to be safe for use with the following U-100 insulin: NovoLog®, Humalog®, Apidra®, Fiasp®, Lyumjev®, or Admelog®. Refer to the Omnipod DASH® Insulin Management System User Guide at omnipod.com for complete safety information including indications, contraindications, warnings, cautions, and instructions.
†Omnipod DASH® 30-Day Free Trial
Terms and Conditions
1. Program Eligibility
Eligibility criteria: Subject to program limitations and terms and conditions, the Omnipod DASH 30-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod DASH prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. The Program is open only to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod® 5, Omnipod DASH or Omnipod Insulin Management System.
This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid in the United States, Puerto Rico, and the U.S. territories. Please contact Insulet Customer Support at 1-800-591-3455 for details.
2. Program Details
With this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following:
• A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropriate platform provided by Insulet’s pharmacy partner.
• Once Insulet, or its pharmacy partner, has received the request, including a valid prescription for the Omnipod DASH Intro Kit and Omnipod DASH Pods, the participant’s benefits will be checked by Insulet or its pharmacy partner.
• If the benefits check results in a monthly copay equal to or below two hundred dollars ($200), then Insulet, or its pharmacy partner, shall issue a one-time only copay card to the participant, for a value equal to the out-of-pocket expenses the participant would have to pay for an Omnipod DASH 30-day initial shipment, in accordance with Section 3, below.
• If the benefits check result in a copay greater than two hundred dollars ($200), Insulet, or its authorized partners, shall arrange for the shipment of one (1) Omnipod DASH Intro Kit, in accordance with Section 4, below.
• For the purpose of clarity, the term “copay” shall encompass any out-of-pocket expense for one (1) month’s supply of Pods, including any deductible, copays and other out-of-pocket expenses that the participant would have to disburse to procure said supply of Pods.
• Any copay assistance may not apply to a participant’s health plan’s deductible if prohibited by state law or by a health plan.
Insulet reserves the right to change, amend or rescind this Program, in whole or in part, at any time.
3. Copay Card
Should participant be deemed eligible to receive an Omnipod DASH Copay Card, participant shall receive electronically one (1) Omnipod DASH Copay Card, valid for a single use, in the amount required for the participant to procure a 30-day supply of Omnipod DASH Pods at a participating pharmacy. In addition, Insulet’s pharmacy partners shall ship, at no cost to participant, one (1) Omnipod DASH Starter Kit, which shall include:
• One (1) Omnipod DASH Personal Diabetes Manager (PDM)
• One (1) Omnipod DASH User Guide
• One (1) PDM charging cable
4. Product Dispense
Should participant be deemed eligible to receive a one-time dispense of Omnipod DASH Pods at no cost to them, Insulet, or its authorized partner, shall dispense one (1) Omnipod DASH Intro Kit, which shall include:
• One (1) Omnipod DASH PDM
• Eleven (11) Omnipod DASH Pods
• One (1) Omnipod DASH User Guide
• One (1) PDM charging cable
The Omnipod DASH Intro Kit shall be delivered to the shipping address indicated by participant in their Acknowledgment Form. Any estimate date of delivery is given solely for participant’s information and does not constitute a warranty that the Intro Kit will be delivered on said date. Participant is responsible to provide an accurate delivery address, to receive shipment of the Intro Kit and to verify the content of the Intro Kit.